Sign In
Buy CSTL
$24.69
-0.795 (-3.12%)
At Close: Jul 24, 2026
Why Castle Biosciences' Rally Might Just Be Getting Started
08:02am, Wednesday, 05'th Nov 2025
Castle Biosciences (NASDAQ:CSTL) rallied more than 20% after delivering a strong Q3 performance. When analyzed through the lens of the Adhishthana Principles, the stock shows clear signs of momentum b
Castle Biosciences, Inc. (CSTL) Q3 2025 Earnings Call Transcript
11:06pm, Monday, 03'rd Nov 2025
Castle Biosciences, Inc. ( CSTL ) Q3 2025 Earnings Call November 3, 2025 4:30 PM EST Company Participants Camilla Zuckero - Vice President of Investor Relations & Corporate Affairs Derek Maetzold - Fo
Castle Biosciences Reports Third Quarter 2025 Results
04:07pm, Monday, 03'rd Nov 2025
Delivered Q3 2025 revenue of $83 million Q 3 2025 non-dermatologic revenue increased by 67% over Q 3 2024 Q 3 2025 total test reports for our core revenue drivers (DecisionDx ® -Melanoma, TissueCyphe
FRIENDSWOOD, Texas, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the launch o
Castle Biosciences (CSTL) Expected to Announce Quarterly Earnings on Monday
02:00am, Saturday, 01'st Nov 2025
Castle Biosciences (NASDAQ: CSTL - Get Free Report) will likely be posting its Q3 2025 results after the market closes on Monday, November 3rd. Analysts expect Castle Biosciences to post earnings of (
Forget Profit, Pick These 4 Stocks With Increasing Cash Flows
01:06pm, Thursday, 30'th Oct 2025
Amid earnings buzz, stocks like RadNet, Mission Produce, Castle Biosciences and FreightCar America stand out for their rising cash flows and resilience.
Castle Biosciences to Participate in Upcoming Investor Conferences
07:00am, Tuesday, 28'th Oct 2025
FRIENDSWOOD, Texas, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its exe
Analysts Estimate Castle Biosciences, Inc. (CSTL) to Report a Decline in Earnings: What to Look Out for
11:06am, Monday, 27'th Oct 2025
Castle Biosciences (CSTL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FRIENDSWOOD, Texas, Oct. 26, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data dem
Castle is presenting data on DecisionDx®-Melanoma and its pipeline atopic dermatitis (AD) test at the 25th Annual Fall Clinical Dermatology Conference.
How Much Upside is Left in Castle Biosciences (CSTL)? Wall Street Analysts Think 50.08%
10:56am, Thursday, 23'rd Oct 2025
The consensus price target hints at a 50.1% upside potential for Castle Biosciences (CSTL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earning
What Makes Castle Biosciences (CSTL) a New Strong Buy Stock
01:01pm, Tuesday, 21'st Oct 2025
Castle Biosciences (CSTL) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Castle Biosciences to Release Third Quarter 2025 Financial Results and Host Conference Call on Monday, Nov. 3, 2025
07:00am, Monday, 13'th Oct 2025
FRIENDSWOOD, Texas, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will
Castle Biosciences' Founder, President and CEO Derek Maetzold Honored with the CEO of the Year Award by The CEO Magazine
04:30pm, Wednesday, 01'st Oct 2025
FRIENDSWOOD, Texas, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its fou
Castle Biosciences Honored with a Greater Pittsburgh Top Workplaces 2025 Award
07:00am, Tuesday, 23'rd Sep 2025
FRIENDSWOOD, Texas, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it ha
